THOUSAND OAKS, Calif.,
Jan. 22, 2015 /PRNewswire/
-- Amgen (NASDAQ:AMGN) today announced that it will report its
fourth quarter and full year 2014 financial results on Tuesday, Jan. 27, 2015, after the close of the
U.S. financial markets. The announcement will be followed by a
conference call with the investment community at 2 p.m. PT. Participating in the call from Amgen
will be Robert A. Bradway, chairman
and chief executive officer, and other members of Amgen's senior
management team.
Live audio of the conference call will be simultaneously
broadcast over the Internet and will be available to members of the
news media, investors and the general public.
The webcast, as with other selected presentations regarding
developments in Amgen's business given by management at certain
investor and medical conferences, can be found on Amgen's website,
www.amgen.com, under Investors. Information regarding presentation
times, webcast availability and webcast links are noted on Amgen's
Investor Relations Events Calendar. The webcast will be archived
and available for replay for at least 90 days after the
event.
About Amgen
Amgen is committed to unlocking the potential of biology for
patients suffering from serious illnesses by discovering,
developing, manufacturing and delivering innovative human
therapeutics. This approach begins by using tools like advanced
human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages
its biologics manufacturing expertise to strive for solutions that
improve health outcomes and dramatically improve people's lives. A
biotechnology pioneer since 1980, Amgen has grown to be one of the
world's leading independent biotechnology companies, has reached
millions of patients around the world and is developing a pipeline
of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on
www.twitter.com/amgen.
CONTACT: Amgen, Thousand
Oaks
Cuyler Mayer, 805-447-6332
(media)
Arvind Sood, 805-447-1060
(investors)
Logo -
http://photos.prnewswire.com/prnh/20081015/AMGENLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2014-fourth-quarter-and-full-year-financial-results-300024551.html
SOURCE Amgen